Back to Results
First PageMeta Content
Interferon beta-1a / Drug discovery / Pharmaceutical sciences / Pharmacology / Serono


Timothy Coetzee, PhD Chief Research Officer MULTIPLE SCLEROSIS • 400,000 patients in US, 2.5 million worldwide
Add to Reading List

Document Date: 2011-03-10 10:35:47

Open Document

File Size: 641,03 KB

Share Result on Facebook

Company

EMD Serono / Pfizer / Fast Forward - EMD Serono Collaborative Fund / New York Times / /

Country

United States / /

Currency

USD / /

Event

Business Partnership / /

IndustryTerm

pharmaceutical partners / /

MedicalCondition

Chief Research Officer MULTIPLE SCLEROSIS / /

Organization

EMD Serono Collaborative Fund / /

Person

Timothy Coetzee / Read / MULTIPLE SCLEROSIS / /

Position

PhD Chief Research Officer / Advocate / Forward / /

Product

Novantrone / Copaxone / Tysabri / Rebif / Betaseron / Avonex / /

PublishedMedium

Fast Forward / New York Times / /

Technology

Drug Discovery / /

SocialTag